US 7541040
Chimeric molecule for the treatment of th2-like cytokine mediated disorders
granted A61KA61K47/642A61K47/646
Quick answer
US patent 7541040 (Chimeric molecule for the treatment of th2-like cytokine mediated disorders) held by The United States of America as represented by the Department of Health and Human Serivces expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Department of Health and Human Serivces
- Grant date
- Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K47/642, A61K47/646, A61K47/6829, A61K47/6849